Clinical trial
A Familiarization and Safety Study of Myocardial Perfusion Contrast Echocardiography With PB127 Ultrasound Contrast Agent in Patients With Suspected Obstructive Coronary Artery Disease
NCT00594698 is registered in ClinicalTrials.gov with Point Biomedical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Familiarization and Safety Study of Myocardial Perfusion Contrast Echocardiography With PB127 Ultrasound Contrast Agent in Patients With Suspected Obstructive Coronary Artery Disease
- Lead sponsor
- Point Biomedical
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- February 28, 2002
- Completion date
- September 30, 2003
- Enrollment
- 150 (actual)
- Sites
- 34
Conditions
As the registry lists them; a condition with its own page is linked.